Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Shares Outstanding (Weighted Average) (2020 - 2025)

NeuroPace (NPCE) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $32.7 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 12.35% year-over-year to $32.7 million; the TTM value through Dec 2025 reached $32.7 million, up 12.35%, while the annual FY2025 figure was $32.7 million, 12.35% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $32.7 million in Q4 2025 per NPCE's latest filing, down from $33.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $33.1 million in Q3 2025 and bottomed at $269178.0 in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $25.2 million, with a median of $25.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 11808.86% in 2021, then grew 1.72% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $16.6 million in 2021, then soared by 48.08% to $24.6 million in 2022, then grew by 5.11% to $25.9 million in 2023, then increased by 12.67% to $29.1 million in 2024, then increased by 12.35% to $32.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $32.7 million in Q4 2025, $33.1 million in Q3 2025, and $32.9 million in Q2 2025.